You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced melanoma

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Worldwide (Pembrolizumab Dose C, Pembrolizumab Dose A, Pembrolizumab Dose B)

Active, not recruiting
  • Melanoma
  • Pembrolizumab Dose C
  • +3 more
  • Orange, New South Wales, Australia
  • +14 more
Jan 19, 2023

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)

Recruiting
  • Locally Advanced Unresectable or Metastatic Melanoma
  • Los Angeles, California
  • +12 more
Jun 30, 2022

Melanoma Trial in Shanghai (SHR-1701, Temozolomide)

Not yet recruiting
  • Melanoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 1, 2021

Immune-related Adverse Event, Diarrhea, Advanced Melanoma Trial in Edmonton (Mesalamine)

Not yet recruiting
  • Immune-related Adverse Event
  • +3 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Dec 15, 2022

Advanced Melanoma, Renal Cell Carcinoma Trial in New Haven (Nivolumab, Ipilimumab, APX005M)

Recruiting
  • Advanced Melanoma
  • Renal Cell Carcinoma
  • New Haven, Connecticut
  • +1 more
Nov 2, 2021

Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

Recruiting
  • Melanoma
  • Siena, Toscana, Italy
  • +11 more
Jun 23, 2023

Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Completed
  • Malignant Melanoma
  • Aarhus, Denmark
    AUH
Feb 16, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)

Recruiting
  • Unresectable Melanoma
  • Metastatic Melanoma
  • NEO-PTC-01
  • Brussel, Belgium
  • +2 more
Dec 5, 2022

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)

Not yet recruiting
  • Melanoma
  • Recombinant human interferon α1b
  • +2 more
  • Xi'an, Shaanxi, China
    Air Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022

Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Advanced Melanoma
  • FMT + ICI
  • Toronto, Ontario, Canada
  • +3 more
Aug 19, 2022

Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)

Active, not recruiting
  • Melanoma (Skin)
  • Blood sampling
  • Dijon, France
  • +3 more
Mar 29, 2022

Bladder Cancer, Melanoma Trial in United States (Nivolumab, Nivolumab plus Ipilimumab)

Active, not recruiting
  • Bladder Cancer
  • Melanoma
  • Farmington, Connecticut
  • +4 more
May 9, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma Trial in Philadelphia (Nivolumab, Hydroxychloroquine, Ipilimumab)

Recruiting
  • Melanoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Sep 15, 2021

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Metastatic Melanoma Trial in Chicago (Photoimmunotherapy)

Terminated
  • Metastatic Melanoma
  • Photoimmunotherapy
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine, Department
Dec 1, 2021

Melanoma Trial (Blood samples, Skin biopsy)

Not yet recruiting
  • Melanoma
  • Blood samples
  • Skin biopsy
  • (no location specified)
Oct 3, 2022

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

Recruiting
  • Malignant Melanoma
  • +3 more
  • SCIB1 DNA vaccine
  • Cardiff, United Kingdom
  • +6 more
Dec 7, 2022

Locally Advanced or Metastatic Melanoma Trial (CBL0137, Ipilimumab, Nivolumab)

Not yet recruiting
  • Locally Advanced or Metastatic Melanoma
  • (no location specified)
Aug 10, 2022

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023